|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
13 December 2021 |
|
Main ID: |
NCT00035503 |
|
Date of registration:
|
03/05/2002 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Multicenter Trial For Patients With Acute Crohn's Disease
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
January 31, 2002 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT00035503 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double.
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Canada
|
United States
| | | | | | |
|
Key inclusion & exclusion criteria
|
- Must have active confirmed Crohn's disease with CDAI > 220 and < 400.
- Otherwise healthy.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Crohn's Disease
|
|
Intervention(s)
|
|
Drug: etiprednol dicloacetate
|
|
Secondary ID(s)
|
|
IXR-201-19-166
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|